A facile system for construction of HSV-1 variants: Site directed mutation of the UL26 protease gene in HSV-1

被引:13
|
作者
Register, RB [1 ]
Shafer, JA [1 ]
机构
[1] MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,RES LABS,W POINT,PA 19486
关键词
herpes simplex virus-1 variants; HSV-1; protease; UL26; Pra;
D O I
10.1016/0166-0934(95)01984-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A 2-plasmid/4-cosmid-based system of mutagenesis is described for construction of herpes simplex virus type 1 (HSV-1) variants with point mutations in the protease gene. The system was used to reconstruct a mutant virus (V701) with Tyr30 to Phe and Ala48 to Val mutations in HSV-1 protease that exhibits the temperature sensitive phenotype of the previously characterized temperature sensitive HSV-1 mutant, ts1201. The 2-plasmid/4-cosmid system of mutagenesis was further validated by using it to construct a virus wherein the active site Ser129 of HSV-1 protease was mutated to Ala. The resulting virus mutant (V713) grew only on the Vero host range cell line PHS-23. In V713 infected Vero cells, the processing of Pra to N-o was almost completely blocked, and B capsids accumulated in the nucleus in crystal-like aggregates, suggesting that protease activity is required for emergence of monodispersed capsids from these aggregates. Back mutation of Ala129 to Ser using the V713 viral DNA as template for PCR mutagenesis restored the wild-type phenotype verifying that the replicative incompetence of V713 reflected only the effect of the Ser to Ala mutation. The 2-plasmid/4-cosmid system of mutagenesis (and modifications thereof) should facilitate production of new mutant viruses for delineating interactions of domains of HSV-1 protease (as well as other HSV-1 proteins) important for virus replication.
引用
收藏
页码:181 / 193
页数:13
相关论文
共 50 条
  • [31] Myristylation and palmitylation of HSV-1 UL11 are not essential for its function
    Baird, Nicholas L.
    Starkey, Jason L.
    Hughes, David J.
    Wills, John W.
    VIROLOGY, 2010, 397 (01) : 80 - 88
  • [32] The exonuclease activity of HSV-1 UL12 is required for in vivo function
    Goldstein, JN
    Weller, SK
    VIROLOGY, 1998, 244 (02) : 442 - 457
  • [33] ANALYSIS OF THE TRANSCRIPTION PATTERN OF HSV-1 UL52 AND UL53 GENES
    MOYAL, M
    BECKER, Y
    VIRUS GENES, 1994, 9 (01) : 15 - 21
  • [34] THE REGION OF THE HSV-1 LAT GENE THAT IS COLINEAR WITH THE ICP34.5 GENE IS NOT INVOLVED IN SPONTANEOUS REACTIVATION IN THE RABBIT OCULAR MODEL OF HSV-1 LATENCY
    WECHSLER, SL
    CHOKEPHAIBULKIT, K
    PERNG, GC
    THOMPSON, RL
    SAWTELL, NM
    GHIASI, H
    NESBURN, AB
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S644 - S644
  • [35] HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis
    Lechanteur, C
    Princen, F
    Lo Bue, S
    Detroz, B
    Fillet, G
    Gielen, J
    Bours, V
    Merville, MP
    GENE THERAPY OF CANCER, 1998, 451 : 115 - 119
  • [36] Induction of HSV-1 gene expression by transcorneal iontophoresis of epinephrine
    Taylor, JL
    Tsao, LS
    Hill, J
    Marquart, ME
    Loutsch, JM
    Zheng, XD
    Varnell, ED
    O'Brien, WJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S762 - S762
  • [37] Development of HSV-1 amplicon vectors for improved gene transfer
    Lam, P
    Ho, IAW
    Lim, KS
    Hui, KM
    CANCER GENE THERAPY, 2004, 11 (12) : 843 - 843
  • [38] TRANSACTIVATION OF HSV-1 IMMEDIATE EARLY GENE-EXPRESSION
    TRIEZENBERG, SJ
    LAMARCO, KL
    MCKNIGHT, SL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 38 - 38
  • [39] EXPERIMENTAL KERATITIS IN RABBITS BY HUMAN HSV-1 VARIANTS - PREVENTION AND TREATMENT
    MANSERVIGI, R
    INCORVAIA, C
    DILUCA, D
    ROTOLA, A
    BALBONI, PG
    SEBASTIANI, A
    ROSSI, A
    CASSAI, E
    JOURNAL OF MEDICAL VIROLOGY, 1990, 32 (03) : 148 - 154
  • [40] AN ANTISENSE OLIGONUCLEOTIDE TO THE HSV-1 UL-13 GENE IS EFFECTIVE AGAINST HERPETIC-KERATITIS
    BRANDT, CR
    COAKLEY, LM
    GRAU, DR
    DRAPER, KG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 854 - 854